海南普利制药有限公司创建于1992年,座落于风景迤俪的南海之滨——海南省海口市美兰区桂林洋经济开发区。是一家专业从事药品生产与研发的医药股份制企业 公司2002年3月整体通过国家gmp认证。 2002年被授予“外商投资技术企业”，同年获得“企业”称号。. 公司秉承‘普利天下、利在健康”的企业宗旨，倡导“认认真真做人，踏踏实实做事”的文化理念，贯彻“诚信、、创新、专业”的经营理念，造福患者，服务社会。. 公司拥有10000平方米gmp洁净厂房，具备片剂、胶囊剂、颗粒剂、干混悬剂、水针剂、冻干剂、软膏剂、原料药八条生产线。拥有从意大利、德国进口的一系列具有国际水平的生产制造设备和的检测仪器。. 公司主要从事缓控释、掩味口崩、冻干、纳米微乳、脂质体、液体胶囊领域药品的研究开发和生产。专注并擅长于药物释放系统（dds系统）的四大类制剂技术：缓控释技术、掩味口崩技术、微乳化技术、纳米冻干技术。. 公司一贯坚持管理创新，技术创新，经过十五年的发展，树立了普利在医药界“技术，品质优良”的良好信誉，为公司的持续健康发展奠定了良好的基础。目前，公司已经在治疗镇痛、脑血管疾病、呼吸系统疾病、消化系统疾病、抗感染、性病等领域推出了一系列技术、品质优良、市场高度认可的药品。. 海南普利已经成为欧美多家国内外知名企业和机构的战略合作伙伴。目前正积极准备通过美国 fda 的cgmp认证，开拓欧美市场。.an introduction to hainan poly pharm. co., ltd.hainan poly pharm. co., ltd. (hainan poly), founded at a beautiful city in south china-- guilinyang economic development area, haikou city, hainan province in 1992 with a registered capital of 30 million rmb yuan, is a new & high-tech stock enterprise specialized in pharmaceutical manufacture and research. in 2006, it’s production value exceeded 0.1 billion rmb yuan..the company obtained the national gmp certificate in march 2002, and was conferred the “advanced technical enterprise of foreign investment” and “national new & high-tech enterprise” at the same year..the company’s tenet is to benefit the world for people’s health, and advocates such cultural philosophies as “be honest in deeds and be steadfast in works”, and such business philosophies as honesty, high-efficiency, innovation and profession..the company possesses 10 thousand square meters’ clean workshop meeting gmp requirements, having 8 production lines for manufacturing tablets, capsules, granulate preparation, dry suspensions, injections, powder for injections, ointments and apis.the company are engaged in research, development and manufacture in fields of sustained and controlled release, taste masking & oral disintegrating, freeze-drying, nanometer-emulsion, liposome and liquid capsule, and specialized in four types of technologies of the dds systems including sustained and controlled release technique, taste masking & oral disintegrating technique, emulsion technique and nanometer-lyophilizing technique..in 15 years’ development, the company has been carrying out management and technical innovation at all times, and has already created a good credit of “advance in technique and high in quality” in pharmaceutical industry, which establishes a good foundation for the company’s continuous and healthy development. at present, the company has marketed a series of drug products with advanced techniques and high quality suitable for treatment of pain relief, cardiovascular disease, respiratory system disease, digestive system disease, anti-infection and venereal disease..the company has become the strategic partner of domestic and foreign famous enterprises and institutes. the company is now actively preparing for getting approved by fda and to market in the us and europe.
